|
Study |
Type of Research |
Status |
| SURE-PD3 | Neuroprotective Agent |
Enrollment closed In follow-up |
| STEADY-PD3 | Neuroprotective Agent |
Enrollment closed In follow-up |
| AADC Gene Therapy for PD | Gene Therapy |
Enrollment closed In follow-up |
| VY-AADC01 Gene Therapy for PD | Gene Therapy |
Enrollment closed In follow-up |
| Cerebrospinal Fluid Biomarkers in PD | Imaging, Biomarkers |
Enrollment closed In follow-up |
| FS ZONE - Study of Pioglitazone as a neuroprotective agent | Neuroprotective Agent |
Enrollment closed In follow-up |
| Phase II - SYN115 | Medication for "wearing off" |
Enrollment closed In follow-up |
| Recognizing atypical forms of PD | Imaging study |
Enrollment closed In follow-up |
| Study of Cerebral Potentials in Parkinson's disease | Electrophysiological Study |
Enrollment closed In follow-up |
|
Neuroprotective Agent
|
Study Terminated. More info here. |
|
| Phase II Neurturin | Gene Therapy |
Enrollment closed In follow-up |
|
Enrollment closed In follow-up |
||
|
Physical therapy |
Enrollment closed In follow-up |
|
|
The effects of the rivastigmine patch on attention and behavior in PD with dementia |
Medication for Cognitive Symptoms |
Enrollment closed In follow-up |
|
Comparison of medications |
Completed |
|
|
Optimal dosage of medication |
Completed |
|
|
Genetics in PD |
Completed |
|
|
Diagnostic device for PD |
Completed |
|
| fMRI Study of PD and Working Memory |
Imaging |
Enrollment closed |
| Parkinsons Disease Signature Imaging |
Imaging, Biomarkers |
Enrollment closed |
| Domain-specific tasks of executive function in PD |
Cognitive study |
Enrollment closed |
| Spatial cognition in neurodegenerative disease |
Cognitive study |
Enrollment closed |
*Click on links for more information on these studies
